[1] APPLETON J P，WOODHOUSE L J，BELCHER A，

et al. It is safe to use transdermal glyceryl trinitrate

to lower blood pressure in patients with acute

ischaemic stroke with carotid stenosis[J]. Stroke

Vasc Neurol，2019，4（1）：28-35.

[2] ENOS Trial Investigators. Efficacy of nitric

oxide，with or without continuing antihypertensive

treatment，for management of high blood pressure in

acute stroke（ENOS）：a partial-factorial randomised

controlled trial[J]. Lancet，2015，385（9968）：617-

628.

[3] SANDSET E C，BATH P M，BOYSEN G，et al.

The angiotensin-receptor blocker candesartan for

treatment of acute stroke（SCAST）：a randomised，

placebo-controlled，double-blind trial[J]. Lancet，

2011，377（9767）：741-750.

[4] HE J，ZHANG Y H，XU T，et al. Effects of

immediate blood pressure reduction on death and

major disability in patients with acute ischemic

stroke：the CATIS randomized clinical trial[J].

JAMA，2014，311（5）：479-489.

[5] ANDERSON C S，HUANG Y，LINDLEY R I，et al.

Intensive blood pressure reduction with intravenous

thrombolysis therapy for acute ischaemic stroke

（ENCHANTED）：an international，randomised，open-label，blinded-endpoint，phase 3 trial[J].

Lancet，2019，393（10 174）：877-888.

[6] RIGHT-2 Investigators. Prehospital transdermal

glyceryl trinitrate in patients with ultra-acute

presumed stroke（RIGHT-2）：An ambulance-based，

randomised，sham-controlled，blinded，phase 3

trial[J]. Lancet，2019，393（10 175）：1009-1020.

[7] HONG L，CHENG X，LIN L，et al. The blood

pressure paradox in acute ischemic stroke[J]. Ann

Neurol，2019，85（3）：331-339.